Biby Reji, APRN

Biby Reji practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Biby Reji's NPI, 1841079571, was assigned on September 22, 2023. Biby Reji holds Texas license 1115137.

Biby Reji's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Biby Reji's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Biby Reji practices. Vendor and product names are available with a free account.

Gerontology is Biby Reji's primary specialty in the NPI Registry, under taxonomy code 363LG0600X. Biby Reji is licensed in Texas.

CMS counts 217 Medicare patients who saw Biby Reji in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 5% are also on Medicaid. Their average risk score is 3.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Biby Reji's median patient age at 73, with 35% women.

In 2024, Biby Reji wrote 534 Medicare Part D claims for 119 patients. 36% of them were for generic drugs.

Biby Reji accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 12 general payments to Biby Reji from 7 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Syndax Pharmaceuticals, Inc. paid the most, $99.